Tag Archives: Hal Gunn

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial

Magic of Qu Crohn’s Panel Discussion

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn’s Disease Vancouver, British Columbia – June 11, 2013 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system, announced it has enrolled its first patient in a …